article thumbnail

Product Highlight: DrugBank Data Dictionary

DrugBank

Your Definitive Source of Truth The Data Dictionary is tailored to transform your data experience, offering the official DrugBank perspective on every piece of information in our database. Enhanced User Experience By offering immediate access to detailed data definitions, the Data Dictionary saves you time and reduces errors.

article thumbnail

#Unshackled: The evolving definition of asset-centricity

DrugBaron

Before long, the story rather than the product candidates themselves have become the principal “asset” of the company. Global pharma companies, at least until recently, didn’t have “stories” linking assets but an uncorrelated pipeline of product candidates chosen for their individual value. New oncology products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Transforming Knowledge Work and Product Development with AI Agents

Perficient: Drug Development

Now more than ever, we’re witnessing a significant shift from simple AI capabilities to action-driven AI Agents that promise to revolutionize how we approach knowledge work, product development, and business processes. Role Definition : A clear, contextual understanding of its purpose and role often within a team.

article thumbnail

CMS Definition of “New Formulation” Upheld in Federal Court

FDA Law Blog: Biosimilars

Kirschenbaum — On March 31, the Federal District Court for the District of Maryland upheld CMS’s definition of a “new formulation” under the Medicaid Drug Rebate Program (MDRP). All of these products are line extensions under CMS’s definition. Vanda Pharmaceuticals, Inc. MJM-22-977 (Dist.

Drugs 59
article thumbnail

The rising impact of biomarkers in early clinical development

Drug Target Review

4 The definition has since evolved and expanded to include molecular signatures of pharmacodynamics and therapeutic response. Investigational products with novel mechanisms of action are also assessed for safety in unique ways, creating complexities that can be more dynamically and effectively monitored using biologically relevant biomarkers.

article thumbnail

Building Azure DevOps CD Processes for SPFx

Perficient: Drug Development

Continuous Deployment (CD) takes validated code packages from the build process and deploys them into a staging or production environment. Installing NodeJS Go to the Tasks tab The task configuration window will appear the same as in the build definition. From the left navigation, click Pipelines > Releases. Name your environment.

article thumbnail

FDA’s Revised Draft Guidance on Biological Product Promotion Provides Additional Recommendations/Clarifications

FDA Law Blog: Biosimilars

This Revised Draft Guidance provides considerations for manufacturers, packers or distributors (dubbed “firms”) of prescription biological reference products, biosimilar products, and interchangeable biosimilar products presenting data and information about such products in promotional materials in a truthful and non-misleading way.